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The method of substrate phage display was used to select a preferred substrate from three monovalent display libraries
using the HSV-1 protease. The display libraries consisted of four random amino acids, six random amino acids, and a
biased library containing four amino acids from the P side of the HSV-1 maturation site followed by four random amino
acids. A series of consensus peptides was synthesized based upon the results from these screens and tested in peptide
cleavage assays. An eight amino acid consensus peptide (LVLASSSF) derived from the phage results was cleaved as
efficiently as a 20-mer maturation site peptide. The selected amino acid sequences also allowed the design of a four amino
acid paranitroanilide substrate for continuous assay of HSV-1 protease. Similar to HCMV protease, these results define P4
to P1 as a minimal substrate recognition domain for the HSV-1 protease and suggest that P4 to P1 is the minimal substrate
domain which all herpesvirus proteases recognize. q 1997 Academic Press
INTRODUCTION including that of the HSV-1 assembly protein (Burck et
al., 1994; Donaghy and Jupp, 1995; Welch et al., 1995).
Herpesviruses encode an essential serine protease The amino acids influencing substrate recognition and
which is involved in the assembly and maturation of viral cleavage of herpesvirus proteases have been investi-
capsids (Gao et al., 1994; Liu and Roizman, 1991; Welch gated in vitro and in vivo (DiIanni et al., 1993; McCann
et al., 1991). The herpes simplex virus (HSV) protease et al., 1994; Sardana et al., 1994; Stevens et al., 1994;
(UL26) is found in intermediate capsid particles and is Welch et al., 1993). Peptide cleavage assays using sub-
responsible for proteolytic processing of itself and the strates truncated at the N-terminus, C-terminus, or both,
viral assembly protein ICP35 (UL26.5) during viral particle identified a P5 to P8* minimum peptide length for efficient
assembly (Gao et al., 1994; Liu and Roizman, 1991; Rob- cleavage by the HSV protease and a P4 to P4* minimum
ertson et al., 1997; Weinheimer et al., 1993). Like the for the HCMV protease in vitro. Also, site-directed muta-
other herpesvirus proteases, the HSV-1 protease is ex- genesis of individual amino acids of the ICP35 substrate
pressed as a precursor protein that autoprocesses at mapped critical recognition elements for HSV-1 protease
two sites, referred to as the release site (R site) and the to residues P4–P1* using an Escherichia coli coexpres-
maturation site (M site). R site cleavage releases the sion system (McCann et al., 1994). The primary determi-
protease catalytic domain from the precursor protein; M nants for substrate recognition and binding in vitro by
site cleavage removes 25 C-terminal amino acids from the HCMV protease were also mapped to the P4–P1*
the precursor. The UL26.5 open reading frame is coinci- positions of the substrate (VVNA-S) (LaFemina et al.,
dent with the carboxyl terminus of the UL26 open reading 1996), while the sequences flanking the conserved core
frame such that the M site is identical in sequence to P4–P1* (LVNA-S) appear to be required for peptide cleav-
the ICP35 cleavage site. The amino acid sequences of age by the HSV-1 protease (DiIanni et al., 1993). In gen-
the R and M cleavage sites are highly conserved among eral, these standard approaches serve to identify critical
the various herpesviruses at the P4–P1* positions amino acids required for cleavage of a given substrate
(Shecter and Berger, 1967), with cleavage typically oc- sequence, but they generally do not identify potential
curring between alanine at P1 and serine at P1* (Tigue amino acid substitutions that would improve substrate
et al., 1996; Welch et al., 1993). While the HSV-1 protease binding and hydrolysis for a given peptide. So, while
fails to cleave substrates encoded by other herpesvi- there is clear value in the results obtained using these
ruses, other herpesvirus proteases have been shown to approaches, the limited number of sequence combina-
process heterologous herpesvirus substrate sequences, tions which can be practically tested has been biased
toward conserved cleavage site sequences.
Kinetic analyses of hydrolysis by the herpesvirus prote-1 To whom correspondence and reprint requests should be ad-
ases using synthetic peptide substrates (Darke et al.,dressed. Fax: (203) 284-6088. E-mail: steven_p._weinheimer@
ccmail.bms.com. 1994; DiIanni et al., 1993; Hall and Darke, 1995; LaFemina
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et al., 1996; Pinko et al., 1995; Sardana et al., 1994; Stevens libraries were constructed and screened with the HSV-
1 protease. The results of these screens are presentedet al., 1994; Tigue et al., 1996) have indicated relatively
low values for the specificity constant, kcat /Km , compared along with peptide cleavage data which confirms the
identification of an optimized 8-mer substrate for theto other serine and viral proteases (Cordingley et al., 1989;
Higgins et al., 1983; Meek et al., 1989; Valenzuela et al., HSV-1 protease that is cleaved with an efficiency similar
to larger peptide substrates. Moreover, this substrate1971). Since proteolytic processing in herpesvirus-in-
fected cells is a very efficient process, it is likely that the is cleaved with the same efficiency in the presence or
absence of glycerol and antichaotrophic salts and is notprotease is operating in a suboptimal mode in vitro. The
synthetic peptide substrates used in these various kinetic cleaved by HCMV protease. Furthermore, we present a
paranitroanilide substrate for HSV-1 protease basedanalyses were based on amino acid sequences which
occur naturally within a constrained protein fold but which upon the results of the substrate phage screen which
defines a minimal recognition sequence for HSV-1 prote-might not accurately mimic the naturally occurring sub-
strate structure. Thus, synthetic peptides might not inter- ase and is suitable for development of a continuous col-
orimetric assay for HSV-1 protease.act with the active site of the protease in the same manner
as the naturally occurring substrate does. As such, alter-
native peptide substrates might be identified with im-
METHODS
proved properties for binding and cleavage by herpesvirus
proteases. In vitro cleavage kinetics for peptide substrates Protease expression
by herpesvirus proteases can also be increased by cosol-
vents present in the reaction mixture as shown by prote- Construction of plasmids containing HCMV protease
(pT7256-A143T/A144T) and HSV-1 protease (pGST247)ase stimulation with glycerol and antichaeotrophic salts
(Hall and Darke, 1995; Yamanaka et al., 1995). Dimeriza- have been described previously (DiIanni et al., 1993;
O’Boyle et al., 1995). The HSV-1 protease fusion proteintion of the HCMV protease has also been shown to result
in higher rates of cleavage (Darke et al., 1996) at enzyme gene was subcloned for baculovirus expression by ligat-
ing the SspI fragment of pGST247 into a BamHI blunt-concentrations of 0.55 mM in 20% glycerol and similar
observations have been made for the HSV-1 protease (C. ended Blue Bac 3 vector (Invitrogen). This fusion prote-
ase has previously been shown to process ICP35 in aDiIanni and D. O’Boyle, unpublished results; Schmidt and
Darke, 1997). bacterial coexpression assay in a similar manner as ei-
ther the catalytic domain or the full-length protease (DiI-It is of interest, therefore, to determine whether alterna-
tive peptide substrates might yield higher in vitro cleav- anni et al., 1993).
age efficiencies. A useful approach to identify and opti-
mize protease cleavage/recognition sites employs the HCMV protease purification
substrate phage methodology (Matthews and Wells,
1993; Roberts et al., 1992, Schatz, 1993). Substrate phage E. coli BL21(DE3) cells were transformed with pT7256-
A143T/A144T and grown at 377 in LB media with shakingdisplay libraries generate vast numbers of substrate se-
quence variants that can be screened using a selection to an OD600 of 0.4–0.6, then induced with 0.1 mM IPTG
for 3 hr. The cells were pelleted and resuspended in 20method that physically separates substrates from non-
substrates. A typical substrate phage construct consists ml lysis buffer/liter of culture [50 mM Tris (pH 8.0), 2 mM
DTT, 5 mM EDTA, 25 mM NaCl, 1 mg/ml lysozyme] usingof an affinity tag and a cleavable polypeptide linker fused
to the gene III minor coat protein of bacteriophage M13. a dounce homogenizer with a ‘‘B’’ pestle, and then Triton
X-100 was added to a final concentration of 1%. AfterThe affinity domain provides a means to immobilize
phage particles that display the fusion protein in the sonication (Branson 250 sonifier set at 50% duty, maxi-
mum output for microtip, 20 pulses), the lysate was centri-phage coat. The linker can be modified to contain an
amino acid sequence cleaved by a protease of known fuged at 15,000 rpm for 30 min at 47. The supernatant
was dialyzed against Q Sepharose Buffer A [50 mM Trisspecificity or to contain a library of randomized amino
acid sequences from which to select substrates for prote- (pH 8.3), 20 mM NaCl, 0.1 mM EDTA, 1 mM DTT] and
then fractionated over a Q Sepharose 26/10 Fast Flowases of new or unknown specificity. Immobilization of
the phage libraries via the affinity domain coupled with column using a gradient of 0.02–1.0 M NaCl. The HCMV
protease peak fractions eluting between 200 and 300repeated cycles of protease cleavage and amplification
of phage particles released by protease cleavage results mM NaCl were pooled, precipitated with 30% ammonium
sulfate, and spun at 10,000 rpm for 20 min at 47. Thein enrichment for phages encoding linker sequences that
are optimized for cleavage by the test protease. supernatant was frozen overnight at 0807, thawed, and
the precipitate pelleted. Both pellets were resuspendedWe have used the substrate phage technique to select
for optimized cleavage sites of the HSV-1 protease. After in a minimum volume of gel filtration buffer [50 mM Tris
(pH 8.3), 100 mM NaCl, 0.1 mM EDTA, 1 mM DTT, 5%developing a substrate phage enrichment protocol using
the HCMV protease, three randomized substrate phage glycerol], pooled, and fractionated over a Superose 12
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Prep Grade 10/50 gel filtration column. The peak frac- BPTI/Dg3p. The OmpA-BPTI coding region was verified
by DNA sequencing. A polypeptide linker containing thetions were pooled, aliquoted, and stored at 0807.
HCMV M site (VVNASCRLATAS) was created between
HSV-1 protease purification BPTI and Dg3p by cloning annealed complimentary
oligonucleotides (5*-GGCCGGTACCGGCCCAGGCGG-
Sf-9 cells at a cell density of 5 1 105 cells/ml were
CGTGGTGAACGCCAGCTGCCGCCTGGCGACCGC-
infected with a recombinant baculovirus expressing the
CAGCGC-3* and 5*-GGCCGCGCTGGCGGTCGCCAG-
HSV-1 protease catalytic domain (Blue Bac 3/HSV-1) at
GCGGCAGCTGGCGTTCACCACGCCGCCTGGGCC-
a multiplicity of infection (m.o.i.) of 0.1. The cells were
GGTACC-3*) into the NotI site, creating phagemid BPTI/
incubated in SF-900 II SFM (Gibco-BRL) at 277 in a 6-
Dg3p/HCMV-M1. The orientation of the oligonucleotide
liter spinner flask for 4 days then harvested at 5,000 g
linker was verified by DNA sequencing. The correctly ori-
at 47 and resuspended in 30 ml lysis buffer [20 mM Tris
entated linker removes the NotI site next to BPTI and
(pH 8.0), 15 mM NaCl, 0.1 mM EDTA, 1 mM DTT]/5 ml
replaces it with a KpnI site (underlined). A phagemid con-
cell pellet. The lysate was adjusted to 1% Triton X-100,
taining the oligonucleotide linker in the reverse orientation
sonicated, and centrifuged at 30,000 g for 30 min at 47.
(BPTI/Dg3p/HCMV-M1rev) was also isolated in which the
Glutathione sepharose beads (Pharmacia) (prewashed
protein product cannot be cleaved by the HCMV protease
51 with 50 ml cold lysis buffer) were added to the super-
(data not shown). Phagemid BPTI/Dg3p/HSV-M1 con-
natant (2 ml beads/30 ml supernatant) and rotated for 40
taining the HSV-1 M site was constructed by annealing
min at 47. The beads were then pelleted at 2,000 g for 5
the oligonucleotides 5*-GGCCGGCCCGGGCGGCCTTGT-
min at 47, washed 51 with 50 ml cold lysis buffer, and
CAACGCCAGCAGCGCAGCACACGTGGACGTTGCGGT-
then eluted 31 with 10 mM reduced glutathione (Sigma)
CCTGGCGTAC-3* and 5*-GCCAGGACCGCCAACGTC-
in lysis buffer. The supernatants were pooled, concen-
CACGTGTGCTGCGCTGCTGGCGTTGACAAGGCCGCC-
trated using a Centriprep 30, and fractionated by gel
CGGGCC-3*, then ligating into the KpnI/NotI sites of BPTI/
filtration using a Superose 12 Prep Grade 10/50 gel filtra-
Dg3p/HCMV-M1. Phagemid libraries designated BPTI/
tion column equilibrated with 50 mM Tris (pH 8.0), 0.1
Dg3p/4-mer, BPTI/Dg3p/biased 8-mer, and BPTI/Dg3p/
mM EDTA, 0.1 M NaCl, 5% glycerol, 1 mM DTT. The peak
6-mer were also generated by ligating annealed oligonu-
fractions of HSV-1 protease were pooled, aliquoted, and
cleotides into the KpnI/NotI sites of BPTI/Dg3p/HCMV-
stored at 0807.
M1. The oligonucleotides for the BPTI/Dg3p/4-mer were
5*-GGCCGGCCCGGGCGGCNNSNNSNNSNNSGG-Phagemids
CGGTCCTGGCGTAC-3* and 5*-GCCAGGACCGCCSNN-
SNNSNNSNNGCCGCCCGGGCC-3*, for the biased 8-merThe phagemid vector pCANTAB5E (Pharmacia) was
used for all the substrate phage constructs, except that library were 5*-GGCCGGCCCGGGCGGCTATCTACAAGC-
ANNSNNSNNSNNSGGCGGTCCTGGCGTAC-3* and 5*-the gene III coat protein was truncated for expression of
only the membrane anchor domain (Dg3p), due to con- GCCAGGACCGCCSNNSNNSNNSNNTGCTTGTAGATA-
GCCGCCCGGGCC-3*, and for the 6-mer library werecerns of protein size interfering with proper processing
and presentation on the M13 phage surface (Lowman, 5*-GGCCGGAGCTGGAGGCCCGGGCGGCNNSNNSNN-
SNNSNNSNNSGGCGGTCCTGGCGGAGCTGGAG-3* and1991). This phagemid, designated pCANTAB5E/Dg3p,
was constructed by standard PCR techniques using 5*-TCCAGCTCCGCCAGGACCGCCSNNSNNSNNSNN-
SNNSNNGCCGCCCGGGCCTCCAGCTCC-3*. N repre-pCANTAB5E as a template with a 5* primer containing a
NotI restriction site (5*-GGCGGCTCTGCGGCCGCCGGC- sents all four nucleotides while S represents G or C. All
phagemid controls and libraries were ligated at a 5:1 mo-TCTGAG-3*) and a 3* primer near the C-terminus of gene
III (5*-CGCAAAGACACCACGG-3*), followed by ligation of lar ratio of insert to vector DNA. The ligated DNA was
used to transform electrocompetent E. coli XL-1 Blue pre-the NotI/NdeI-digested PCR product into pCANTAB5E and
confirmation by DNA sequencing. The coding sequence pared and electroporated according to the manufacturer’s
instructions (Bio-Rad). Following electroporation, an ali-for bovine pancreatic trypsin inhibitor (BPTI) fused to the
OmpA signal sequence, for secretion from E. coli, was quot was removed to determine the transformation fre-
quency for each library and the remaining cells were di-cloned upstream of Dg3p by standard PCR techniques
using pTI103 (Goldenberg, 1988) as a template and four luted in 21 YT/ T/ G (YT medium plus 50 mg/ml tetracy-
cline and 2% glucose) and allowed to grow at 377 until anoligonucleotides 5* - CTCTCAAGCTTCTAAATAACGAGG -
CGCAAAAAATGAAAAAGACAGC-3*, 5*-GGAGGCTCT- OD of 0.5 was reached at which time M13K07 helper
phage were added at an m.o.i. of 3.0 along with ampicillinAGACAGAAGTCAGGC-3*, 5*-CCTGACTTCTGTCTAGAG-
CCTCC-3*, and 5*-TACCGAGCTCGCGGCCGCACCACC- to 50 mg/ml. The cells were grown for 1 hr at 377, pelleted
at 1,700 g for 10 min, and resuspended in 21 YT con-ACAGGTCCTCATGC-3* as primers. The BPTI affinity
domain was cloned into pCANTAB5E/Dg3p by ligation taining 50 mg/ml ampicillin and 70 mg/ml kanamycin. After
overnight shaking at 377, the cells were pelleted at 1,700of the HindIII/XbaI-digested and XbaI/NotI-digested PCR
products (sites underlined above), creating phagemid g for 10 min and the supernatant was stored at 47 or used
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for cycling following concentration by PEG/NaCl precipita- glycerol, 1% DMSO] in a reaction volume of 50 ml. Incuba-
tions were at 307 for 40 min, except where shorter ortion (described in Smith and Scott, 1993).
longer times were required to measure linear reaction
Cycling of substrate phage rates reliably. Reactions were terminated by the addition
of 150 ml 8 M guanidine HCl. The amount of peptide
Phage were concentrated by adding 200 ml concentrat-
cleavage was determined by integrating the area under
ing buffer (20% PEG 8000, 2.5 M NaCl) to 1 ml phage
the product and substrate peaks separated by a HPLC
stock for 15 min at room temperature, pelleted at 16,000
C18 column (Vydac) developed with an acetonitrile (0–
g for 5 min, and resuspended in 50 ml TBS [2.5 mM Tris
100%)/TFA (0.05–0.1%) gradient monitored at 215 nM. All
(pH 8.0), 250 mM NaCl, 0.27 mM KCl]. Prior to immobiliza-
reported rates represent reactions that converted 20%
tion for screening, blocking solution (144 ml 1% Oval-
of the substrate.
bumin in TBS, 4 ml 5% Triton X-100, 2 ml 100 mM CaCl2)
was added to the phage and the mixture was rotated for
Paranitroanilide assays
30 min at room temperature. At the same time, a slurry
of anhydrotrypsin agarose beads (100 ml, Panvera Corp.) A paranitroanilide substrate, NH2-LVLA-pNA (Synpep,
was spun briefly at 16,000 g, and then the beads were Inc.) was dissolved in 100% DMSO to a final concentra-
resuspended in blocking solution (180 ml 1% Ovalbumin tion of 100 mM. An aliquot was removed and diluted to
in TBS, 2 ml 100 mM CaCl2) and rotated for 30 min at 10% DMSO and used for assays. Reactions (200 ml) in a
room temperature. The blocked beads and phage were flat 96-well plate contained the same buffer as described
both centrifuged at 16,000 g, and then the bead pellet for peptide cleavage assays except BSA was included
was resuspended with the phage supernatant and this to 0.5 mg/ml. Progress curves were followed at 405 nM
mixture was rotated for 2 hr at room temperature to im- using a Molecular Dynamics plate reader in kinetics
mobilize phage particles displaying functional BPTI fu- mode at room temperature followed by analysis using
sion protein. The beads were then pelleted at 16,000 g Softmax and Microsoft Excel software. Product concen-
for 1 min, washed 151 with 1 ml wash buffer 1 [TBS, 2.5 trations were calculated based upon the equation mol/
mM Tris (pH 8.0), 250 mM NaCl, 0.27 mM KCl, 0.1% L  absorbance 405 nM/8800 cm01 for a standard solu-
Tween 20, 1 mM CaCl2], 31 with 1 ml wash buffer 2 [50 tion of paranitroaniline dye.
mM sodium citrate (pH 3.0), 1 mM CaCl2], and 31 with
1 ml wash buffer 3 [14 mM Tris (pH 8.0), 28 mM EDTA, RESULTS
6.9 mM NaCl, 14% glycerol, 1 mM CaCl2 , 1 mg/ml BSA].
Validation of substrate phage enrichmentEach wash consisted of a 3-min rotation at room temper-
ature followed by a 1-min spin at 16,000 g. The washed
The HCMV protease was used to develop methods for
beads were resuspended in 200 ml wash buffer 3, divided
the amplification of a cleavable herpesvirus substrate
into two tubes, and pelleted at 4,000 g for 5 min. The
phage diluted in a mixture of noncleavable substrate
bead aliquots were each resuspended in 50 ml protease
phage, simulating the screen of a randomized substrate
reaction buffer [1.25 M Na2SO4 , 1 mM CaCl2 , 19 mM HSV- phage display library. It was presumed that the HCMV
1 protease (10 mM HCMV protease) or an equal amount
protease would achieve this result more readily than the
of BSA by weight] and rotated for 15 min at 277. After
HSV-1 protease due to its ability to cleave shorter peptide
incubation the beads were pelleted at 4,000 g for 5 min,
substrates, its higher specific activity, and its broader
and then 40 ml of the supernatant was added to 2 ml LB
substrate specificity. Control substrate phagemids were
media, followed by an equal volume of E. coli XL-1 Blue
constructed for this purpose: BPTI/Dg3p/HCMV-M1 en-
(Stratagene) at an OD600 of 0.5 in LB media with 50 mg/ codes the HCMV M site from P4–P8* (VVNA f SCRLA-
ml tetracycline. A small aliquot was removed from each
TAS) and BPTI/Dg3p/HCMV-M1rev encodes a substrate
sample to measure transduction frequencies for the re-
sequence (VARQLAFTTPP) not cleaved by HCMV prote-
leased phage particles by plating aliquots onto LB/ampi-
ase. These phagemid inserts both contain an asymmetric
cillin plates. The remaining sample was grown to an
restriction enzyme site which allowed for their identifica-
OD600 of 0.5 and processed as described for the tion and quantification by restriction enzyme digestion.
phagemid library growth.
To assess the selective power for HCMV protease, a
ratio of one cleavable substrate phage (M1) in one millionPeptide cleavage assays
noncleavable substrate phages (M1rev) was immobilized
on anhydrotrypsin agarose and subjected to substratePeptides synthesized by Research Genetics (Hunts-
ville, AL) were resuspended in 100% DMSO and diluted to amplification by HCMV protease. This involved repeated
cycles of HCMV protease digestion followed by amplifi-10% DMSO immediately before use. Cleavage reactions
contained: 1 mM HSV-1 protease, peptide substrate [from cation of phage particles released by the HCMV protease
(as described under Materials and Methods). After the25 to 250 mM, varied for kinetic analysis, 10 mM NaPO4
(pH 7.4), 150 mM NaOAc, 1 mM DTT, 0.1% CHAPS, {20% fifth round of enrichment by HCMV protease treatment,
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95% of the released phage contained the HCMV M site, naturally occurring herpesvirus protease cleavage sites
and would provide the best opportunity to select for novelas determined by restriction enzyme analysis. The ex-
pected fold enrichment of substrate phage per cycle of recognition elements. This library contained 6.2 1 107
transformants, again achieving a 99% confidence levelprotease selection was monitored for each cycle by de-
termining the titer of phage released by protease diges- for completeness, and was designated BPTI/Dg3p/bi-
ased 8-mer (8-mer library). The first round yielded a sig-tion of the HCMV-M1 control phage (signal) versus the
titer using no protease (noise). The average signal-to- nal-to-noise ratio of 6 while subsequent rounds released
phage only from reactions containing protease. The rapidnoise ratio per cycle was approximately 15, consistent
with the detection of 1 substrate in 106 after five enrich- selection of specifically released phage likely resulted
from the inclusion of the P side HSV-1 recognition se-ment cycles (155  7.6 1 105). This result demonstrated
that a rare cleavable substrate could be isolated from a quence. The amino acid sequences of phage clones iso-
lated after the sixth round of selection from the 8-merlarge population of noncleavable substrates.
library using HSV-1 protease are presented in Table 1(A).
We concluded from these results that the HSV-1 proteaseScreening of randomized substrate phage display
displayed a preference for serine at P1*, serine  threo-libraries
nine at P3*, and frequently selected serine  threonine
 alanine at P2*. A slight preference for the aromatic,Three different randomized substrate phage libraries
were constructed to select for the smallest cleavable hydrophobic amino acids phenylalanine or tyrosine at
P4* was also observed. Except for Ser and Thr at P3*,substrate for the HSV-1 protease. We reasoned that
smaller substrates might possess amino acid sequences the most frequently selected amino acids conformed to
the naturally occurring sequence of either the HSV-1 Mwith improved binding and recognition for the HSV-1 pro-
tease active site. In each library the randomized insert or R cleavage site.
As the HSV-1 protease was clearly able to cleave thewas flanked on either side by the amino acids GGPGG
to disrupt any neighboring secondary structure that might linker with eight amino acid positions inserted, but not
four amino acids, the third library screened consisted ofinfluence protease cleavage. The first library constructed
was BPTI/Dg3p/4-mer which contained four randomized six randomized positions (BPTI/Dg3p/6-mer). This library
was constructed to determine whether any combinationpositions and was screened to determine whether four
amino acids might be recognized as a substrate. This of six amino acids would allow for efficient substrate
recognition and cleavage by the HSV-1 protease; it con-library consisted of 7.31 106 independent transformants,
yielding a 99% confidence level for completeness, mean- tained 6.0 1 108 independent transformants, yielding a
confidence level under 90%. The signal-to-noise for thising that the library should contain all possible amino acid
sequences as calculated assuming a Poisson distribu- library from the first round of selection was 1.1 and even-
tually increased to 14 by the sixth round of selection. Thetion (Clackson and Wells, 1994). After five rounds of en-
richment, the 4-mer library did not yield an increase in amino acid sequences of individual isolates from the
sixth round of selection are presented in Table 1(B). Thesignal-to-noise when compared to the control phage con-
taining the HSV-1 M site cycled simultaneously under sequences in Table 1(B) were aligned by assuming that
alanine and serine occupied the P1 and P1* positions ofthe same conditions. That no selection was observed
might indicate that the HSV-1 protease could not cleave the presumptive scissile bonds. A consensus amino acid
sequence based on this alignment suggested that thea four amino acid substrate efficiently or did not recog-
nize the substrate in the context of the linker chosen. protease selected for a core recognition sequence com-
prising five amino acid residues spanning the P4–P1*Since the M site control phage could be recognized in
this context, we concluded that the protease could not positions. The consensus amino acids at four of the five
positions were conserved in naturally occurring HSV-1cleave any combination of four amino acids efficiently.
The minimal peptide length for cleavage by the HCMV cleavage sites (R or M site). The most striking amino
acid consensus occurred at the P4 and P1* positionsprotease was reported to be eight amino acids (LaFem-
ina et al., 1996). Since the HSV-1 and HCMV proteases where leucine and serine, respectively, were selected
exclusively. At the P1 position, too, alanine was alsoare likely to be structurally closely related and might
have similar substrate binding sites, a second library strongly selected in 13 of 14 isolates, whereas aliphatic
amino acids (mostly leucine and valine) occurred at everywas generated to determine whether the HSV-1 protease
could also recognize an eight amino acid substrate. The P3 position. At the remaining position, P2, the preferred
amino acid was clearly leucine, a surprising observation8-mer library was constructed with four randomized P*
residues adjacent to four invariant P side amino acids in that neither leucine nor any other aliphatic residues
occur at the P2 position in either the wild-type R or Mfrom the HSV-1 R site (YLQA), producing a polypeptide
linker of the sequence GGPGG-YLQA-XXXX-GGPGG. We site of HSV-1. We concluded that the protease preferred
the naturally occurring amino acids at every position ex-elected to first randomize the P* side of the HSV-1 cleav-
age site because these residues are not conserved in cept for the P2 position.
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TABLE 1
SITE P5 P4 P3 P2 P1 P1* P2* P3* P4*
HSV-1 M A L V N A S S A A
HSV-1 R T Y L Q A S E K F
(A) P1* P2* P3* P4* P1* P2* P3* P4* (B) P5 P4 P3 P2 P1 P1* P2*
1. S S S S 16. S C S L 1. L V L A S Q
2. S S S F 17. S N S I 2. L V L A S T
3. S S S F 18. S S T Y 3. L L C A S V
4. S S S A 19. S S V F 4. G L I L A S
5. S S S A 20. S A T Y 5. L L W A S T
6. S S S L 21. S L T A 6. P L V F A S
7. S S S M 22. S M T C 7. L V L A S T
8. S A S V 23. S M T Q 8. A L L F A S
9. S A S T 24. S T T Q 9. L L M A S V
10. S A S H 25. S V V G 10. L I L A S G
11. S T S H 26. S A V P 11. E L L L C S
12. S T S F 27. S Q V F 12. L I L A S Q
13. S L S A 28. A E R Y 13. L V L A S N
14. S L S P 29. H A I Y 14. G L V L A S
15. S E S Y
Note. The top two sequences are from the HSV-1 wild-type M and R cleavage sites, respectively. (A) Sequences of 29 individual isolates from
the sixth round of selection from the biased 8-mer library BPTI/Dg3p/biased 8-mer (GGPGG-YLQA-XXXX-GGPGG) screened with the HSV-1 protease.
(B) Sequences of 14 individual isolates from the sixth round of selection from the 6-mer library BPTI/Dg3p/6-mer (GGPGG-XXXXXX-GGPGG) screened
with the HSV-1 protease. The sequences are aligned along the presumptive scissile bond.
Relative hydrolysis rates for consensus-derived in Table 2 by comparing the wild-type M site 8-mer to
consensus peptide 2 (P4* alanine r phenylalanine), con-peptide substrates
sensus peptides 2 and 3 (P2 asparagine r leucine), and
The data from the substrate phage screens were used
consensus peptides 3 and 5 (P3* alanine r serine). The
to design synthetic peptide substrates. If the phage selec-
overall effect of each of these substitutions is to increase
tion process reflected sequence preferences for cleavage
the efficiency of hydrolysis of the 8-mer peptide by 140-
site recognition, it should be possible for peptide sub-
fold compared to the wild-type M site 8-mer. Cleavage
strates to be selected with improved cleavage efficiencies.
of consensus peptide 5 by the HCMV protease was not
Hence, a number of 8 or 10 amino acid consensus se-
detected in the presence or absence of glycerol (data
quences were generated by combining P side residues
not shown), consistent with previously published substrate
selected from the 6-mer library with P* side residues se-
lected from the biased 8-mer library. Table 2 shows the
TABLE 2relative cleavage rates of various consensus peptides
compared to the naturally occurring HSV-1 M sequence
(P4–P6*) as well as to a previously published 20-mer se- Relative
HSV-1 site Peptide sequence ratequence (P12–P8*) (DiIanni et al., 1993). Relative rates
were normalized against the 10-mer M site peptide which
M (P12-P8*) ASNAEAGALVNA SSAAHVDV 83was assigned a value of 1. Whereas a number of the
M (P4-P6*) LVNA SSAAHV 1.0
consensus peptides were not cleaved efficiently, consen- M (P4-P4*) LVNA SSAA .65
sus peptide 5 which contained the 8-mer sequence LVLA R (P4-P6*) YLQA SEKFKM 3.1
PR/P*M (P4-P6*) YLQA SSAAHV 1.2f SSSF, was surprisingly cleaved at a rate 90 times faster
PM/P*R (P4-P6*) LVNA SEKFKM 7.1than the wild-type 10-mer peptide and just as efficiently as
Consensus 1 (P4-P6*) LVNA SSAFHV 5.9the wild-type 20-mer M site peptide. The smallest peptide
Consensus 2 (P4-P4*) LVNA SSAF 0.75
substrate for the HSV-1 protease reported previously to Consensus 3 (P4-P4*) LVLA SSAF 7.7
be cleaved this efficiently was a 13-mer, P5–P8* (DiIanni Consensus 4 (P4-P4*) LVLA SSSA 11
Consensus 5 (P4-P4*) LVLA SSSF 92et al., 1993). This dramatic increase in cleavage efficiency
of a small peptide was the result of three amino acid
Note. Relative cleavage rates of four wild-type HSV-1 cleavage sitechanges from the HSV-1 wild-type M site sequence. The
peptides of varying length (M, maturation site, R, release site), two
three substitutions were asparagine to leucine at P2, ala- peptides which fuse the P and P* side residues of the HSV-1 wild-type
nine to serine at P3*, and alanine to phenylalanine at P4*. M and R sites, and five consensus peptides derived from the data of
the biased 8-mer and 6-mer libraries.The effect of each amino acid substitution can be seen
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analysis indicated a kcat of 0.054 min
01 for the 10-mer M
site and 2.9 min01 for the consensus 8-mer. The enzyme
may exist in a dimer-monomer equilibrium under the
assay conditions used (20% glycerol, 0.5 mM enzyme,
227) as noted for HCMV (Kd  0.55 mM, 20% glycerol, 307;
Darke et al., 1996; Schmidt and Darke, 1997) making
these kinetic constants low estimates of their true values.
The Km values determined for the M site 10-mer and
the consensus 8-mer peptides were 280 and 400 mM,
respectively, indicating that, in contrast to the large differ-
ence seen for the Kcat values, the overall effect of the
substitutions is to increase the turnover number while the
binding of the peptide is relatively unaffected (or could be
explained by the two amino acid decrease in length).
These data revealed a specificity constant for the opti-
FIG. 1. Lineweaver–Burke plot comparing the HSV-1 wild-type 10-
mized 8-mer, LVLASSSF, of 121 M01s01. This measure-mer M cleavage peptide versus the optimized 8-mer consensus peptide
ment is greater than any previously reported for a peptide5. Each point represents the average of at least three determinations.
substrate of the HSV-1 protease in the absence of activat-
ing cosolvents.
specificity for herpesvirus proteases (Burke et al., 1994;
Welch et al., 1995). Characterization of paranitroanilide substrate
The sequences from the 8-mer library and the 6-mer
A paranitroanilide (pNA) substrate for the HSV-1 prote-library screen presented in Table 1 were noted to yield
ase was synthesized based upon the P side sequence ofa P side maturation site-like sequence and a P* side
LVLA derived from the phage library screen. This reagentrelease site-like sequence. This suggested that a chime-
would provide a convenient colorimetric measurementric cleavage site based on natural sequences might be
of protease activity and allow the design of a sensitive,a better substrate than either the natural M or R site
easily quantitated, continuous assay. A progress curvepeptides. This hypothesis was tested using peptides in
is presented in Fig. 2 (top panel), which shows thewhich the M site or R site amino acids were exchanged
change in absorbance at 405 nM in the presence of two(Table 2). Both chimeras (PR/P*M , PM/P*R) were cleaved
concentrations of HSV-1 protease and varying substratewith efficiencies resembling the wild-type M and R sites,
concentrations. Efficient cleavage was seen using 500indicating tolerance for the chimeric amino acids substi-
nM HSV-1 protease and could occur in the absence oftution, though neither was cleaved with the efficiency of
any activating cosolvent. The HSV-1 pNA substrate wasconsensus peptide 5.
not cleaved by HCMV protease, trypsin, or a crude E.
coli extract (data not shown). Kinetic analyses presentedEffect of activating cosolvents
in Fig. 2 (bottom panel) using the initial velocities from
the progress curves in Fig. 2 (top panel) yield a Km of 2The herpesvirus proteases require the presence of
high concentrations of glycerol or antichaeotrophic salts mM and a kcat of 20 min
01 deriving a specificity constant
of kcat/Km of 100 M
01s01. This value is consistent withfor efficient activation of in vitro hydrolysis (Hall and
Darke, 1995; Yamanaka et al., 1995). The effects of these values reported by Darke (1996) and DiIanni (1993) for
13- and 14-mer peptide substrates of HSV-1 (40 M01s01),cosolvents were examined in cleavage reactions with
consensus peptide 5. A two- to fourfold stimulation of indicating that this new assay substrate can provide effi-
cient recognition and cleavage.hydrolysis was observed in the presence of 1.25 M
Na2SO4 or 20% glycerol, while an approximate 100-fold
stimulation was observed for the M site peptide (P4– DISCUSSION
P6*), which was assayed in parallel (data not shown).
This report describes the selection of optimized HSV-This property has never been reported previously for any
1 protease substrates by substrate phage display, thesubstrate of a herpesvirus protease.
identification of an 8 amino acid optimer peptide sub-
strate consisting of residues P4–P4* and a paranitroanil-Cleavage kinetics of consensus peptide 5 (P4–P4*)
ide substrate derived from these observations. Synthesisand an M site peptide (P4–P6*)
and analysis of several consensus peptides as well as
chimeric peptides in which the M and R site P side andHydrolysis of consensus peptide 5 and the 10-mer M
site control peptide were subjected to Lineweaver – P* side amino acids were exchanged indicated that only
two peptides were cleaved efficiently in vitro. A 20-aminoBurke analysis and kinetic constants were derived (Fig.
1). Assuming a monomeric and totally active protein, this acid M site peptide (P12–P8*) and an 8-amino acid con-
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tyrosine) is found in the R sites of HSV-1, VZV, and EHV
(Tigue et al., 1996). The P2 change within the conserved
core indicates that a nonconservative replacement in this
region provides HSV protease with a more efficiently
cleaved substrate and may suggest that other herpesvi-
rus proteases can recognize and more efficiently cleave
substrates containing nonconservative amino acids.
The influence of enzyme activation by glycerol or
Na2SO4 was minimal for this substrate. This is in contrast
to the dramatic stimulation of peptide cleavage reported
by Hall and Darke (1995) and by Yamanaka et al. (1995)
for larger peptide substrates. It has been suggested that
the effect of these cosolvents is to activate the protease
by dimerization, causing a dramatic decrease in the Km
accompanied by a conformational change in the prote-
ase. It is not clear why dimerization would enhance
cleavage of, say, a 13-mer peptide, but not a closely
related 8-mer. Hydrolysis of the consensus 8-mer peptide
by the HSV-1 protease might instead be due to specific
interactions with this peptide substrate that induce the
appropriate contacts normally mediated through cosol-
vent effects. Similar possibilities have been proposed
previously for the HCMV protease (Darke et al., 1996)
and trypsin protease (Corey et al., 1995). The efficient
cleavage in the absence of cosolvents might also reflect
a combination of factors such as the hydrophobic nature
on the P side and the hydroxyl residues on the P* side
of the substrate which might allow directed and efficient
interaction with the HSV protease under the assay condi-
tions. In any case, this study defines a novel 8-mer con-
sensus peptide substrate and a four amino acid assay
substrate which are both cleaved efficiently by the HSV-
1 protease in vitro. The novel peptide substrate also pos-
sesses the remarkable property of not requiring activat-FIG. 2. Top, Representative progress curve titrating the paranitroanil-
ing cosolvents for stimulation of hydrolysis by the HSV-ide substrate LVLA-pNA (1 mM to 250 mM) in the presence of glycerol
at 1 mM HSV-1 protease. Bottom, A Lineweaver–Burke plot derived 1 protease.
from the progress curves for HSV-1 protease using the pNA substrate Sardana et al. (1994) concluded that a P4–P4* peptide
(LVLA-pNA) with or without glycerol. The points represent the velocities was the minimal length required for efficient cleavage of
derived using the initial 200 min from each progress curve.
a peptide substrate by the HCMV protease and that resi-
dues P3 and P4 were essential for activity. More recently,
a peptide spanning P4–P1 was shown to be a competitivesensus peptide (P4–P4*) had comparable cleavage rates
that were 10 times higher than rates for other peptides inhibitor of HCMV protease cleavage in vitro, emphasizing
the contribution of P side residues to substrate recognitiontested, as indicated by an increase in the specificity con-
stant kcat/Km . In the consensus 8-mer substrate, a leucine (LaFemina et al., 1996). Earlier reports from our group
(DiIanni et al., 1993; McCann et al., 1994) found a coreat P2, serine at P3*, and phenylalanine at P4* were all
crucial for enhanced cleavage, as indicated by reduced requirement of residues P4–P1* for the HSV-1 protease,
also indicating the importance of the P side residues. Thisrelative cleavage rates for peptides individually substi-
tuted for these amino acids. Consensus sequences for suggests that the nonconservative substitution of leucine
for asparagine at the P2 position is a determinant for HSV-the M and R sites of 16 sequenced herpesvirus assem-
blin homologues have a core of (V/L/I)-(D/E/N/Q)-A f S 1 cleavage of the consensus 8-mer substrate on the P
side. The peptide cleavage data in Table 2 shows a 10-and Y-(V/L/I)-(K-Q)-A f (S/N/T) (Hall and Gibson, 1996).
Comparison of positions P2, P3*, and P4* to the cleavage fold increase when the P2 amino acid is changed from
asparagine (consensus peptide 2) to leucine (consensussites of other herpesviruses show an absence of leucine
at P2 in both the R and M sites; the P3* serine is found peptide 3), supporting this conclusion.
A paranitroanilide substrate was synthesized basedin the HCMV, SCMV, and EHV R sites and the EBV M
site, while the P4* hydrophobic moiety (phenylalanine or upon the phage library and peptide cleavage results and
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was shown to be hydrolyzed by HSV-1 protease, but not boundaries and optimal sequences for substrate recogni-
tion, binding, and cleavage by viral proteases.by other serine proteases. This is the first published re-
port of a paranitroanilide substrate being recognized and
cleaved by a herpesvirus protease. Comparison of the ACKNOWLEDGMENTS
specificity constant of the paranitroanilide substrate
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